IP Library Granted Patent US 9,499,804
Granted Patent B2
US 9,499,804 · App. 14/765,795 · Granted Nov 22, 2016

Cyclodextrin glucanotransferase

Inventors: Elizabeth Jenkinson (Abingdon, GB); Preben Krabben (Didcot, GB); Amanda Harding (Abingdon, GB)
Assignee: GREEN BIOLOGICS LTD
C12N9/1074C12P7/06C12P7/065C12P7/16C12P7/28C12P7/52C12Y204/01019Y02E50/10Y02E50/17
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,499,804
App. No.
14/765,795
Granted
Nov 22, 2016
Kind
B2
Abstract

The present invention relates to a novel cyclodextrin glucanotransferase (CGTase) enzyme which is obtainable from Clostridium saccharoperbutylacetonicum N1-4, N1-4(HMT) or N1-504. The invention further relates to nucleic acids encoding the enzyme, vectors and host cells, and uses of the CGTase.

Claims (37)

1. An expression vector comprising a nucleic acid molecule, wherein the nucleotide sequence of the nucleic acid molecule:

(a) encodes the amino acid sequence set forth in SEQ ID NO: 1 or 3;

(b) encodes a cyclodextrin glucanotransferase (CGTase) having at least 80% amino acid sequence identity with SEQ ID NO: 1 or 3;

(c) is set forth in SEQ ID NO: 2 or 4; or

(d) has at least 80% sequence identity with the nucleotide sequence set forth in SEQ ID NO: 2 or 4, and which encodes a CGTase.

2. The expression vector of claim 1 , wherein the expression vector additionally comprises one or more genetic elements selected from the group consisting of antibiotic resistance genes, genes conferring tolerance to heavy metals, auxotrophy genes, origins of replication and insertion sequences.

3. The expression vector of claim 1 , wherein the nucleic acid molecule is present in an operon in association with one or more nucleic acid molecules which encode polypeptides which are involved in starch metabolism.

4. The expression vector of claim 3 , wherein the polypeptides which are involved in starch metabolism are selected from the group consisting of a maltose binding protein periplasmic precursor, a neopullanase/cyclomaltodextrinase, one or more maltose/maltodextrin ABC transporter permease proteins, an alpha amylase catalytic domain protein and a glycogen debranching protein.

5. A host cell comprising the expression vector of claim 1 .

6. The host cell as claimed in claim 5 , wherein the host cell is a bacterial cell.

7. The host cell as claimed in claim 6 , wherein the bacterial cell is of the genus Clostridium or Bacillus.

8. The host cell as claimed in claim 5 , wherein the host cell is a biphasic bacteria.

9. The host cell as claimed in claim 5 , wherein the host cell is selected from the group consisting of C. acetobutylicum, C. aurantibutyricum, C. beijerinckii, C. thermocellum, C. thermobutyricum, C. pasteurianum, C. kluyveri, C. saccharobutylicum, C. thermosaccharolyticum, C. saccharolyticum, C. saccharoperbutylacetonicum, C. tyrobutyricum, C. butyricum, C. puniceum, C. diolis and C. roseum ; or the host cell is a Cluster I Clostridia.

10. A recombinant host cell comprising a heterologous nucleic acid molecule integrated into the host cell genome, wherein the nucleotide sequence of the heterologous nucleic acid molecule:

(a) encodes the amino acid sequence set forth in SEQ ID NO: 1 or 3;

(b) encodes a cyclodextrin glucanotransferase (CGTase) having at least 80% amino acid sequence identity with SEQ ID NO: 1 or 3;

(c) is set forth in SEQ ID NO: 2 or 4; or

(d) has at least 80% sequence identity with the nucleotide sequence set forth in SEQ ID NO: 2 or 4, and which encodes a CGTase,

wherein the host cell is neither Clostridium saccharoperbutylacetonicum N1-4 (HMT) nor Clostridium saccharoperbutylacetonicum N1-504.

11. The recombinant host cell of claim 10 , wherein the heterologous nucleic acid molecule additionally comprises one or more genetic elements selected from the group consisting of promoters, terminators, antibiotic resistance genes, genes conferring tolerance to heavy metals, auxotrophy genes, origins of replication and insertion sequences.

12. The recombinant host cell of claim 10 , wherein the heterologous nucleic acid molecule is present in an operon in association with one or more nucleic acid molecules which encode polypeptides which are involved in starch metabolism.

13. The recombinant host cell of claim 12 , wherein the polypeptides which are involved in starch metabolism are selected from the group consisting of a maltose binding protein periplasmic precursor, a neopullanase/cyclomaltodextrinase, one or more maltose/maltodextrin ABC transporter permease proteins, an alpha amylase catalytic domain protein and a glycogen debranching protein.

14. The recombinant host cell as claimed in claim 10 , wherein the recombinant host cell is a bacterial cell.

15. The recombinant host cell as claimed in claim 14 , wherein the bacterial cell is of the genus Clostridium or Bacillus.

16. The recombinant host cell as claimed in claim 10 , wherein the recombinant host cell is a biphasic bacteria.

17. The recombinant host cell as claimed in claim 10 , wherein the recombinant host cell is selected from the group consisting of C. acetobutylicum, C. aurantibutyricum, C. beijerinckii, C. thermocellum, C. thermobutyricum, C. pasteurianum, C. kluyveri, C. saccharobutylicum, C. thermosaccharolyticum, C. saccharolyticum, C. saccharoperbutylacetonicum, C. tyrobutyricum, C. butyricum, C. puniceum, C. diolis and C. roseum ; or the host cell is a Cluster I Clostridia.

18. A host cell comprising a nucleic acid molecule integrated into the host cell genome, wherein the nucleotide sequence of the nucleic acid molecule:

(a) encodes the amino acid sequence set forth in SEQ ID NO: 1 or 3;

(b) encodes a cyclodextrin glucanotransferase (CGTase) having at least 80% amino acid sequence identity with SEQ ID NO: 1 or 3;

(c) is set forth in SEQ ID NO: 2 or 4; or

(d) has at least 80% sequence identity with the nucleotide sequence set forth in SEQ ID NO: 2 or 4, and which encodes a CGTase,

wherein the nucleic acid molecule is operably associated with a constitutive promoter.

19. A host cell comprising two or more nucleic acid molecules integrated into the host cell genome, wherein the nucleotide sequence of the nucleic acid molecules:

(a) encodes the amino acid sequence set forth in SEQ ID NO: 1 or 3;

(b) encodes a cyclodextrin glucanotransferase (CGTase) having at least 80% amino acid sequence identity with SEQ ID NO: 1 or 3;

(c) is set forth in SEQ ID NO: 2 or 4; or

(d) has at least 80% sequence identity with the nucleotide sequence set forth in SEQ ID NO: 2 or 4, and which encodes a CGTase.

Assignments (10)
CORRECTIVE ASSIGNMENT TO CORRECT THE THE EXECUTION DATE FOR THE CONVEYING PARTY PREVIOUSLY RECORDED ON REEL 68257 FRAME 254. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Mar 4, 2025
From: BIOCLEAVE LIMITED
To: BCL2020 LTD
Reel/Frame 070779/0847 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 10, 2024
From: BCL2020 LIMITED
To: NCIMB LIMITED
Reel/Frame 067950/0317 →
CHANGE OF NAME Recorded Jul 9, 2024
From: GREEN BIOLOGICS LIMITED
To: BIOCLEAVE LIMITED
Reel/Frame 068256/0143 →
ASSET PURCHASE AGREEMENT Recorded Jul 9, 2024
From: BIOCLEAVE LIMITED
To: BCL2020 LTD
Reel/Frame 068257/0254 →
RELEASE OF SECURITY INTEREST Recorded Nov 5, 2018
From: THE WEITZ COMPANY, LLC; RYAN AND ASSOCIATES, INC.; INTERSTATES CONSTRUCTION SERVICES INCORPORATED; INDUSTRIAL CONSTRUCTION & ENGINEERING CO.; THE SCAFFOLD COMPANY, LLC
To: GREEN BIOLOGICS, INC.; GREEN BIOLOGICS, LIMITED
Reel/Frame 047409/0436 →
RELEASE OF SECURITY INTEREST Recorded Nov 5, 2018
From: OBSIDIAN AGENCY SERVICES, INC.
To: GREEN BIOLOGICS LIMITED
Reel/Frame 047409/0037 →
NOTIFICATION OF CHANGE OF ADDRESS Recorded May 23, 2018
From: GREEN BIOLOGICS LIMITED
To: GREEN BIOLOGICS LIMITED
Reel/Frame 047304/0556 →
SECURITY INTEREST Recorded Aug 24, 2017
From: GREEN BIOLOGICS LIMITED
To: OBSIDIAN AGENCY SERVICES, INC.
Reel/Frame 043392/0406 →
SECURITY INTEREST Recorded Jan 3, 2017
From: GREEN BIOLOGICS, INC.; GREEN BIOLOGICS LIMITED
To: THE WEITZ COMPANY, LLC; RYAN & ASSOCIATES, INC.; INTERSTATES CONSTRUCTION SERVICES, INC.; INDUSTRIAL CONSTRUCTION AND ENGINEERING, CO.; THE SCAFFOLD COMPANY, LLC
Reel/Frame 040827/0498 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 4, 2016
From: JENKINSON, ELIZABETH; KRABBEN, PREBEN; HARDING, AMANDA
To: GREEN BIOLOGICS LTD
Reel/Frame 038461/0859 →
Priority Claims (2)
GB 1302030.0 · Feb 5, 2013 · national
GB 1303595.1 · Feb 28, 2013 · national
Continuity (1)
Related Publication 20150368623A1 · Dec 24, 2015